Timothy Daley
Stock Analyst at Wells Fargo
(2.02)
# 2,896
Out of 5,182 analysts
55
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $38.41 | +15.75% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.78 | +318.41% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $86.77 | +9.48% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $36.55 | +96.99% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $115.55 | +25.49% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,282.45 | +1.37% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $309.87 | -8.03% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $177.25 | +39.35% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $169.80 | +61.96% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $263.80 | +2.35% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $9.54 | +193.50% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $16.18 | +116.32% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $469.71 | +10.71% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.29 | +2,997.04% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $117.60 | +57.31% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $162.28 | +35.57% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $102.17 | +115.33% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $7.90 | +254.43% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $196.27 | -28.67% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $54.19 | +66.10% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $38.41
Upside: +15.75%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.78
Upside: +318.41%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $86.77
Upside: +9.48%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $36.55
Upside: +96.99%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $115.55
Upside: +25.49%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,282.45
Upside: +1.37%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $309.87
Upside: -8.03%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $177.25
Upside: +39.35%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $169.80
Upside: +61.96%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $263.80
Upside: +2.35%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $9.54
Upside: +193.50%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $16.18
Upside: +116.32%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $469.71
Upside: +10.71%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.29
Upside: +2,997.04%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $117.60
Upside: +57.31%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $162.28
Upside: +35.57%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $102.17
Upside: +115.33%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $7.90
Upside: +254.43%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $196.27
Upside: -28.67%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $54.19
Upside: +66.10%